Medical Weight Loss with
Semaglutide
At Rejuvené, our weight loss program revolves around the tremendous success of Semaglutide and Tirzepatide in helping people lose those unwanted pounds. Our program is designed with your overall health, well-being and safety in mind. We use compounded Semaglutide. We strongly encourage proper eating and exercise habits to obtain optimal results and will provide guidelines for you to implement lifestyle changes that will impact your long-term health and prosperity.
While the Louisiana State Board of Medical Examiners requires that a physician licensed in the state of Louisiana evaluate every patient in a weight management program, we take it a step further. Because we believe that there is additional value in having an actual physician operate the program, we not only have a physician perform the initial evaluation but also have that physician continue to monitor each client throughout the program. We perform screening labs that assess your blood, thyroid, liver and kidney, as well as your electrolytes, cholesterol, lipids and testosterone hormone level. Below is an outline of our weight loss program(s).
IMPORTANT NOTE: Semaglutide should not be used in patients with a history of multiple endocrine neoplasia, medullary thyroid cancer, family history of medullary thyroid cancer, insulin-dependent diabetes, diabetes utilizing sulfonylureas or patients with history of low blood sugar (hypoglycemia). If you have any of the above, you will not be eligible to start Semaglutide and should not register for our program.
Read more about our specific programs:
CLIENTS NEW TO SEMAGLUTIDE
CLIENTS ON SEMAGLUTIDE/TIRZEPATIDE & CONVERTING TO OUR PROGRAM
CLIENTS ASSOCIATED WITH A BUSINESS AFFILIATE
FAQs
-
• Semaglutide is a glucagon-like peptide-1 (GLP-1) agonist that stimulates insulin release from the pancreas. Glucagon-like peptide -1 is a natural hormone that helps your body regulate your blood glucose.
• Semaglutide was first approved by the FDA for weight loss under the name of Wegovy in June of 2014.
-
• By increasing insulin production, Semaglutide helps your body burn calories.
• Semaglutide slows down the speed at which food travels through your digestive system (your stomach empties more slowly), causing you to eat less.
• Semaglutide acts on your brain’s hunger signal causing you to feel full, resulting in weight loss.
-
• Semaglutide is administered as a subcutaneous injection once a week.
• It is started at a low dose to minimize side effects.
• Doses adjustments are considered every 4 weeks as needed.
-
• The recommended starting dose of Semaglutide for weight loss is typically 0.25 mg once a week for the first four weeks. This is followed by an increase to 0.5 mg once a week. Some patients, however, may benefit from an increased dose to 1 mg once a week.
• Like any medication, a qualified physician can determine the optimal dosage for your weight loss needs.
-
• Clinical studies have shown that Semaglutide can help to produce significant weight loss in overweight and obese individuals. Controlled trials showed that participants who took Semaglutide lost an average of 15% to 20 % of their body weight over 68 weeks, compared to an average of 2.4% weight loss in those who received a placebo.
-
• Weight loss results will vary from person to person, but clinical studies have shown that Semaglutide can help to produce significant weight loss in overweight and obese individuals.
• In clinical trials for Ozempic, participants lost an average of 13.5 pounds over 26 weeks when used in combination with moderate diet and exercise.
• In a 68-week study, participants taking Ozempic lost up to 20% of their body weight and those on Wegovy lost an average of 16.0% of their initial body weight, compared to 5.7% for those taking a placebo.
• Weight loss results are significantly better when combining Semaglutide with proper diet and exercise.
-
• Most people will start seeing a decrease in their appetite, the sensation of being fuller faster and a decrease in their food intake in their first month. However, the entry dose is to allow your body to adjust to the new medication and to limit potential side effects. The entry dose is not considered an effective dose for significant weight loss.
• Expect to see better results after starting the higher doses. It usually takes about 8-12 weeks to titrate to the higher doses if you do not develop significant side effects.
-
• This depends on your personal weight loss goals and how well you incorporate proper eating and exercise habits into your weight loss regimen. Clinical studies conducted were for 1 year or greater, but many people see significant weight loss of up to 30 pounds in 6 months.
• Semaglutide for weight loss is not designed to be taken long term. Once your personal goals are achieved, the physician will consider discontinuing the medication. At Rejuvene MedSpa and Wellness Center, we will work with you to achieve long term lifestyle changes that include good diet and exercise habits to maintain your new look and good health.
-
• Because Semaglutide mimics the body’s natural substances, replicating a hormone that the body produces naturally, it is generally well-tolerated and considered quite safe when prescribed by a qualified physician.
• The most common side effects of Semaglutide for weight loss include nausea, heartburn, vomiting, and constipation.
• Less common side effects include abdominal pain, pancreatitis, gallbladder stones or inflammation, acute kidney injury, low blood glucose, electrolyte imbalance, diabetic retinopathy, headache, fatigue and suicidal ideation.
These side effects typically subside over time, as the patient’s body gets used to the medication and they learn the routine of the new reduced fat and caloric intake.
-
• Most patients who take Semaglutide find that they do not need additional weight management medications.
• However, Semaglutide should not be used in combination with other GLP-1 receptor agonists or medications that increase GLP-1 receptor activity. It may be used in combination with other weight loss medications, but the safety and efficacy of such combinations have not been studied.
• Any medications you are taking or wish to take at the same time as Semaglutide should be discussed with a qualified physician.
-
• Semaglutide is also approved for the treatment of Type II diabetes for those who do not take Insulin or Sulfonylureas (Amaryl, Glucotrol, Micronase, Tolinase)
• Semaglutide should not be used by patients with Type I or insulin dependent diabetes.
-
• There is limited information available about the safety of Semaglutide during pregnancy or breastfeeding. If you are pregnant or breastfeeding or plan to get pregnant, you should generally refrain from taking Semaglutide for weight loss.
• However, if Semaglutide (Ozempic) is being prescribed for patients with Type II or with gestational diabetes, it should be discussed with your obstetrician or endocrinologist.
-
• Semaglutide is recommended for adults who have a body mass index (BMI) of 30 kg/m² or greater, or for those with a BMI of 27 kg/m² or greater and at least one weight-related health condition such as high blood pressure, Type II diabetes, or high cholesterol.
• Semaglutide is also recommended for those who have tried to lose weight through diet and exercise but have been unsuccessful.
• Note: Individuals who have a history of pancreatitis or thyroid cancer should not use Semaglutide.
• It is important to talk to your healthcare provider to determine if Semaglutide is a good option for you.
PROGRAM INFORMATION
Clients New to Semaglutide/Tirzepatide
New to Semaglutide or Tirzepatide? Please read the information below to learn more about how to get started with Semaglutide/Tirzepatide weight loss treatments at Rejuvené MedSpa and Wellness Center in downtown New Orleans.
If you have additional questions, concerns or an experience you would like to share with Dr. Reed regarding the Semaglutide/Tirzepatide program, please email AskDrReed@rejuvenemedspa.com.
REGISTER ONLINE
Complete the program registration form and all program intake forms.
When completing the program registration form, you will choose your preferred Labcorp or Quest location (for required labwork) as well as the date for your lab tests. Program registration requires an appointment and lab fee. For clients who are not currently using Semaglutide or Tirzepatide, the appointment fee is $199 and lab fee is $100.
COMPLETE LABWORK
After completion of Step 1, the lab tests will be ordered at your chosen location. Labs should be performed in the morning and after fasting for at least 8 hours. You must complete your labs within 24 hours of your chosen time or the tests will be automatically cancelled.
INITIAL APPOINTMENT WITH DR. PHILLIP L. REED
After receipt of clinical intake forms and completed labwork, our program coordinator will contact you to schedule your initial appointment with Dr. Reed.
For your initial appointment, you will come to our office where the physician will complete the physical exam, review your labs and start the subcutaneous injections. Injections are once a week at a fee of $90 per injection for Semaglutide and $100 per injection for Tirzepatide for Cycle 1. This fee covers the cost of the medication, shipping and handling, physician monitoring and administrative fees. The dosage is increased in increments depending on how the client responds. The cost of the medicine is dependent on the dose needed and increases with increasing dosage.
WEEKLY ASSESSMENT
Your weight, BMI, review of side effects, progress with diet and exercise compliance will be assessed weekly in the office. Your circumference at your umbilicus (belly button), hip, thigh and upper arm will be measured every 4 weeks. In addition, every 4 weeks we will review how well you are moving towards the goals that you set at the beginning of the program.
DOSING CYCLE ADJUSTMENT
You will be considered for a dose adjustment after every 4 injections (dosing cycle). You will receive the first two 4-week dosing cycles in the office (8 injections) and will be taught how to perform your own injections to continue at home after the initial eight injections.
MONTHLY VISIT & INJECTION REFILL
After the initial 8 injections in the office, you will begin self-injecting at home. You will have an office visit every 4 weeks (at a fee of $15 per visit) for an assessment and review of your progress. At this time, you will receive your Semaglutide/Tirzepatide to take home for the next dosing cycle.
The cost of the medicine is dependent on the dose needed.
The total cost per 4-week injection cycle for Semaglutide is as follows:
0.25 mg = $300
0.5 mg = $340
0.75 mg = $375
1.0 mg = $400
1.25 mg = $425
1.5 mg = $450
1.75 mg = $475
2.0 mg = $500
2.2 mg = $525
The total cost per 4-week injection cycle for Tirzepatide is as follows:
2.5 = $400
5.0 mg = $450
7.5 mg = $475
10 mg = $500
12.5 mg = $550
15 mg = $600
Please Note: The entire process (from program registration to initial appointment with Dr. Reed) can take up to 14 days depending on when you can schedule your labs and physician appointment.
PROGRAM INFORMATION
Clients on Semaglutide/Tirzepatide & Converting to our Program
Currently on Semaglutide or Tirzepatide and looking to convert to our program at Rejuvené MedSpa and Wellness Center in downtown New Orleans? Please read the information below to learn how to get started.
If you have additional questions, concerns or an experience you would like to share with Dr. Reed regarding the Semaglutide program, please email AskDrReed@rejuvenemedspa.com.
PROGRAM REGISTRATION
Complete the program registration form and all program intake forms.
When completing the program registration form, you will also choose your preferred Labcorp or Quest location (for required labwork) as well as the date for your lab tests. Program registration requires an appointment and lab fee. For clients who are currently using Semaglutide or Tirzepatide and converting to our program, the appointment fee is $150 and lab fee is $100.
COMPLETE LABWORK
After completion of Step 1, the lab tests will be ordered at your chosen location. Labs should be performed in the morning and after fasting for at least 8 hours. You must complete your labs within 24 hours of your chosen time or the tests will be automatically cancelled.
INITIAL APPOINTMENT WITH DR. PHILLIP L. REED
After receipt of clinical intake forms and completed labwork, our program coordinator will contact you to schedule your initial appointment with Dr. Reed.
At your initial appointment, you will come to our office where the physician will complete the physical exam, review your labs and dispense your Semaglutide or Tirzepatide for the 4-week dosing cycle.
WEEKLY ASSESSMENT
Your weight, BMI, review of side effects, progress with diet and exercise compliance will be assessed weekly in the office. Your circumference at your umbilicus (belly button), hip, thigh and upper arm will be measured every 4 weeks. In addition, every 4 weeks we will review how well you are moving towards the goals that you set at the beginning of the program.
MONTHLY MONITORING & ASSESSMENT
You will have an office visit every 4 weeks (at a fee of $15 per visit) for an assessment and review of your progress. At this time, you will receive your Semaglutide/Tirzepatide to take home for the next dosing cycle. The cost of the medicine for the 4-week dosing cycle depends on the dose.
The total cost per 4-week injection cycle for Semaglutide is as follows:
0.25 mg = $300
0.5 mg = $340
0.75 mg = $375
1.0 mg = $400
1.25 mg = $425
1.5 mg = $450
1.75 mg = $475
2.0 mg = $500
2.2 mg = $525
The total cost per 4-week injection cycle for Tirzepatide is as follows:
2.5 = $400
5.0 mg = $450
7.5 mg = $475
10 mg = $500
12.5 mg = $550
15 mg = $600
PROGRAM INFORMATION
Clients Associated With A Rejuvené Business Affiliate
If you are a client of a Rejuvené business affiliate and are interested in beginning Semaglutide injections at your affiliate’s place of business, please read the information below to learn about our program.
If you have additional questions, concerns or an experience you would like to share with Dr. Reed regarding the Semaglutide program, please email AskDrReed@rejuvenemedspa.com.
PROGRAM REGISTRATION
Complete the program registration form and all program intake forms. There is a place on the form to indicate that you are joining an affiliate program and list the affiliate’s name.
When completing the program registration form, you will also choose your preferred Labcorp or Quest location (for required labwork) as well as the date for your lab tests. Program registration requires an appointment and lab fee. For clients who are not currently using Semaglutide or Tirzepatide, the appointment fee is $199 and lab fee is $100.
COMPLETE LABWORK
After completion of Step 1, the lab tests will be ordered at your chosen location. Labs should be performed in the morning and after fasting for at least 8 hours. You must complete your labs within 24 hours of your chosen time or the tests will be automatically cancelled.
INITIAL APPOINTMENT
After receipt of the intake forms and labs, the business affiliate will contact you for an appointment at the affiliate’s place of business. At your initial appointment, a physician will evaluate you, discuss goals and objectives and review your labs via a televisit. An onsite provider will complete the physical exam and start the subcutaneous injections. Injections are once a week at a fee of $90 per injection for Semaglutide and $100 per week for Tirzepatide and are to be paid to Rejuvené MedSpa and Wellness Center in advance for each 4-week dosing cycle. This fee covers the cost of medication, shipping and handling, medical monitoring and administrative fees.
WEEKLY ASSESSMENT
Your weight, BMI, review of possible side effects, progress with dieting and exercising will be assessed weekly. Your circumference at your umbilicus (belly button), hip, thigh and upper arm will be measured every 4 weeks. In addition, every 4 weeks we will review how well you are moving towards the goals that you set at the beginning of the program.
DOSE CYCLE ADJUSTMENT
You will be considered for a dose adjustment after every 4 injections (dosing cycle). You will receive the first two 4-week dosing cycles in the office (8 injections) and will be taught how to perform your own injections to continue at home after the initial eight injections.
AT-HOME INJECTIONS & MONTHLY ASSESSMENT
After the initial 8 injections in the office, you will begin self-injecting at home. You will have an office visit every 4 weeks (at a fee of $15) for an assessment and review of your progress. At this time, you will receive your Semaglutide for the next dosing cycle, if needed.
MONTHLY MONITORING & ASSESSMENT
For self-injecting at home after the initial 8 weeks, you will pay a monthly monitoring and assessment fee of $150 plus the cost of medicine. There will be a shipping and handling charge of $50. The cost of the medicine is dependent on the dose needed.
The total cost per 4-week injection cycle for Semaglutide is as follows:
0.25 mg = $300
0.5 mg = $340
0.75 mg = $375
1.0 mg = $400
1.25 mg = $425
1.5 mg = $450
1.75 mg = $475
2.0 mg = $500
2.2 mg = $525
The total cost per 4-week injection cycle for Tirzepatide is as follows:
2.5 = $400
5.0 mg = $450
7.5 mg = $475
10 mg = $500
12.5 mg = $550
15 mg = $600
Ready to get started?
Join our program to begin your weight loss journey with Semaglutide today!
